… retrospective multicentre study that included 193 IBD patients… -TNF therapy has been
associated with hepatitis B virus [HBV… risk of hepatotoxicity in patients treated with ustekinumab. A …

… safe and effective options for the treatment of moderate-to-severe plaque psoriasis; ustekinumab
… anti-IL-23 therapy represents a fourth-line option behind treatments with better evidence…

… of response in a retrospective, multicenter study [Citation65]. … in patients undergoing
treatment with anti-Tumor Necrosis … time may be needed to observe ustekinumab full effect. …

… patients based on one retrospective study; among three child … Citation77 Ustekinumab has
also been reported as effective for … In an open-label, multicenter, Phase 3 study Citation87 (…

… non-skin cancer risk were anti-tumor necrosis factor (anti-TNFs) … (LTBI), reactivation of the
hepatitis B virus (HBV), and the … We found three studies evaluating ustekinumab and the risk …

… The estimated prevalence of chronic hepatitis B virus (HBV) in the … Other studies have
concluded that ustekinumab is safe to … In a prospective, multicenter study of patients with HCV …

… For this reason, anti-tumor necrosis factor therapies have … titers checked, and undergo
hepatitis B and C serologic studies [21]. … A 2021 retrospective study investigated the efficacy of …

… We reviewed safety profile of anti-tumor necrosis factor … ), natalizumab and vedolizumab,
ustekinumab, tofacitinib and, … for hepatitis B screening prior to initiating anti-TNF therapy and …

… exposed to other anti–tumor necrosis factor agents or other … A retrospective, observational,
multicenter study on UC and CD … hepatitis B virus infection and tuberculosis (TBC) infection. …

… retrospective studies or case series claimed that 45 mg ustekinumab also had excellent
efficacy… We highly recommend that patients have the T-SPOT TB test and serum hepatitis B (HBV…